The document summarizes clinical data from a study of thalassemic patients, including their age of onset and current age, sex, pre- and post-transition serum ferritin and pre-transfusional hemoglobin levels, chelation therapy regimens, pre- and post-transition cardiac T2* measurements, and pre- and post-transition liver iron concentration (LIC) levels. The mean age of onset was 47 months with a range of 32-62 months. There were slightly more male than female patients. Serum ferritin and LIC levels decreased after transitioning patients to different chelation therapy regimens.
The document summarizes clinical data from a study of thalassemic patients, including their age of onset and current age, sex, pre- and post-transition serum ferritin and pre-transfusional hemoglobin levels, chelation therapy regimens, pre- and post-transition cardiac T2* measurements, and pre- and post-transition liver iron concentration (LIC) levels. The mean age of onset was 47 months with a range of 32-62 months. There were slightly more male than female patients. Serum ferritin and LIC levels decreased after transitioning patients to different chelation therapy regimens.
The document summarizes clinical data from a study of thalassemic patients, including their age of onset and current age, sex, pre- and post-transition serum ferritin and pre-transfusional hemoglobin levels, chelation therapy regimens, pre- and post-transition cardiac T2* measurements, and pre- and post-transition liver iron concentration (LIC) levels. The mean age of onset was 47 months with a range of 32-62 months. There were slightly more male than female patients. Serum ferritin and LIC levels decreased after transitioning patients to different chelation therapy regimens.
Table 1. Clinical data of studied Thalassemic patients
Age at onset(months) Range Mean(SD) Age(years) Range Mean(SD) Sex M F Serum ferritin(ng/dL)(meanSD) Pre-transition Post-transition Pre-transfusional hemoglobin(g/dL)(meanSD) Pre-transition Post-transition Chelation(meanSD)